DaVita stock gained 1.33 percent on October 2

Published on 10/04/2026 at 18:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DaVita stock delivered Q2 2026 revenue of USD 3.554 billion and adjusted EPS of USD 4.02. Analysts cite a Moderate Buy consensus and USD 233.43 target for the shares.

Modernes Dialysezentrum mit Pflegepersonal und Patienten in heller Klinikumgebung — DaVita Inc. Dialysezentrum mit modernen Behandlungsstühlen und medizinischem Pflegepersonal in Denver, ISIN US23918K1088, Illustration mit AI erstellt.

DaVita stock (ISIN US23918K1088) closed at USD 178.69 on the NYSE on October 2, 2026, gaining 1.33 percent from the prior session. Yahoo Finance reported that the move outpaced the S&P 500 gain of 0.73 percent, while attention turned toward the next quarterly report.

Q2 earnings set the baseline

DaVita generated USD 3.554 billion in revenue in Q2 2026, up 5.2 percent from the year-earlier quarter, while diluted EPS reached USD 4.02. Operating income was USD 579 million and the operating margin was 16.3 percent in the same period, according to Quartr.

The company reaffirmed adjusted EPS guidance of USD 14.10-15.20 for fiscal year 2026, alongside adjusted operating income guidance of USD 2.15-2.25 billion. The Q2 figures therefore provide a quantified comparison between current performance and the full-year framework rather than a new annual forecast.

Analyst target remains above price

MarketBeat reported a Moderate Buy consensus from 7 analysts on September 18, 2026. The average 12-month price target was USD 233.43, with recent targets ranging from USD 215.00 to USD 270.00.

Against the October 2 price of USD 178.69, the average target lies 30.64 percent above the stock. The same MarketBeat report said TD Cowen upgraded DaVita to Buy and raised its target from USD 201.00 to USD 220.00 on August 7, 2026, adding a dated analyst catalyst to the earnings picture.

Stock stays below yearly high

DaVita's October 2 range was USD 176.27 to USD 180.08, with volume of 451,529 shares. The 52-week range was USD 101.00 to USD 247.49, leaving the closing price 27.80 percent below the yearly high and placing valuation expectations against a wide trading span.

For investors, the central tension is clear: Q2 revenue grew 5.2 percent and EPS reached USD 4.02, while the consensus target remains materially above the latest close. The next market test is whether the company can convert its fiscal 2026 guidance into another period of operating profit growth.

DaVita stock closed at USD 178.69

DaVita stock closed at USD 178.69 on the NYSE on October 2, 2026, with a daily gain of 1.33 percent. Its market capitalization was USD 11.5 billion on that date.